Exclusive: AstraZeneca chief insists - we will prosper without Pfizer takeover

Dive in US giant’s share price cuts value of offer

AstraZeneca’s chief executive, Pascal Soriot, has told The Independent of his intense belief that his company will produce more breakthrough medicines alone and without Pfizer’s takeover.

Ahead of a grilling by MPs of him and the boss of Pfizer in Parliament this week, Mr Soriot declared: “We are creating and investing in new drugs which we believe will transform how we tackle diseases and change patients’ lives. It is through this process that we create real value for our shareholders.”

In words Mr Soriot will reiterate to the Commons Business Select Committee this week, he added: “Our message is clear. We have transformed the business and are confident in our ability to continue to execute on our independent strategy and generate significant value for shareholders.”

Mr Soriot has stated from the beginning of the bid battle that he believes AstraZeneca has been transformed over the past two years to have what he described to The Independent as “one of the most exciting pipelines of new products in the industry”.

Mr Soriot is back in London having met investors in London and the United States last week. He and his opposite number at Pfizer, Ian Read, are being prepared by their lobbying advisers, RLM Finsbury (for AstraZeneca) and Brunswick (for Pfizer), on how to respond to the barrage of questions they will face from MPs in the gruelling two-day hearing starting tomorrow.

Pfizer is not expected to come back with a higher offer until after those meetings.

Meanwhile, analysis by this newspaper of its last bid, made on 2 May, highlights that $2.7bn (£1.6bn) has been wiped from the offer’s “£63bn” value due to the subsequent collapse in the American company’s share price. This is because it is offering to pay AstraZeneca shareholders mostly in Pfizer shares – a factor that has put off many investors almost as much as the perceived low offer price itself.

With Pfizer’s share price tumbling 10 per cent since the latest bid, pressure is mounting on the US company’s board both to raise the overall value and to increase the proportion of the payment to be made in cash rather than in Pfizer’s erratic shares.

Before the fall in Pfizer’s stock value, the increased offer was worth some £50 a share for AstraZeneca. Investors are looking for nearer to £60, but have told AstraZeneca’s board that it should start talking to the Americans when they next make a higher offer, even though it is likely to come in far lower than that.

The political battle around the bid continued yesterday as the Prime Minister repeated his party’s  warm words towards Pfizer. David Cameron told the BBC: “Don’t underestimate the power of some of the things they have already said, about making sure, for instance, 20 per cent of their R&D jobs will be here in the UK.” That was in reference to the letter of reassurance on jobs in the UK from Mr Read which Labour has described as “not worth the paper it’s written on”.

The shadow Business Secretary, Chuka Umunna, has written to his opposite number in government, Vince Cable, to push for a change to the Enterprise Act 2002, extending the provisions allowing a public interest test in takeovers of British companies. Mr Umunna stressed that such a test did not require primary legislation and could be achieved quickly enough to affect the AstraZeneca move.

Start your day with The Independent, sign up for daily news emails
News
ebookA unique anthology of reporting and analysis of a crucial period of history
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Neil Pavier: Management Accountant

£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...

Sheridan Maine: Commercial Accountant

£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...

Laura Norton: Project Accountant

£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...

Day In a Page

Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

Laughter, but no tears, as Letterman takes his bow after 33 years

Veteran talkshow host steps down to plaudits from four presidents
Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

Hozier's 'blasphemous' song takes Novello award

Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

Join the tequila gold rush

The spirit has gone from a cheap shot to a multi-billion pound product
12 best statement wallpapers

12 best statement wallpapers

Make an impact and transform a room with a conversation-starting pattern
Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

Paul Scholes column

Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?